137391-68-5,
(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate,
(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate,
(3S,4R)-3-[(1R)-1-Hydroxyethyl]-4-[(1R)-1-methyl-3-diazo-3-(p-nitrobenzyloxycarbonyl)-2-oxopropyl]azetidin-2-one,
SCHEMBL306132,
CTK8C0549,
DTXSID10720045,
FDXUXRZSNNSUGD-NRMKKVEVSA-N,
PUBCHEM_57009450,
C17H18N4O7,
ANW-64881,
ZINC35635583,
AKOS016005347,
AJ-91921,
AX8234883,
TC-153626,
ST24035497,
2-Azetidinebutanoic-a-14C acid, a-diazo-3-(1-hydroxyethyl)-g-methyl-b,4-dioxo-,(4-nitrophenyl)methyl ester, [2R-[2a(R*),3b(R*)]]- (9CI),
2-Azetidinebutanoic-alpha-14C acid, alpha-diazo-3-(1-hydroxyethyl)-gamma-methyl-beta,4-dioxo-, (4-nitrophenyl)methyl ester, [2R-[2alpha(R*),3beta(R*)]]- (9CI),
4-nitrobenzyl (4R)-2-diazo-4-[(2R, 3S)-3-{(1R)-1-hydroxyethyl}-4-oxoazetidin-2-yl]-3-oxopentanoate,
4-nitrobenzyl (4R)-2-diazo-4-[(2R,3S)-3-{(1R)-1-hydroxyethyl}-4-oxoazetidin-2-yl]-3-oxopentanoate,
4-nitrobenzyl (4R)-2-diazo-4-[(2R,3S)-3-{(1R)-1-hydroxyethyl}-4-oxoazetidin-2-yl]3-oxopentanoate,
4-nitrobenzyl (4R)-2diazo-4[(2R,3S)-3-{(1R)-1-hydroxyethyl}-4-oxoazetidin-2-yl]3-oxopentanoate,
4-Nitrobenzyl (R)-2-diazo-4-((2R,3S)-3-((R)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate,
86421-06-9,
Meropenem intermediates F9,
Meropenemintermediates(F9),
CID11234678,
CID 11234678,